デング熱(Dengue)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Dengue - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Dengue Overview 9
Therapeutics Development 10
Pipeline Products for Dengue – Overview 10
Pipeline Products for Dengue – Comparative Analysis 11
Dengue – Therapeutics under Development by Companies 12
Dengue – Therapeutics under Investigation by Universities/Institutes 16
Dengue – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Dengue – Products under Development by Companies 22
Dengue – Products under Investigation by Universities/Institutes 26
Dengue – Companies Involved in Therapeutics Development 28
Agilvax, Inc. 28
AltraVax Inc. 29
Arbovax, Inc. 30
BioDiem Ltd 31
Biotron Limited 32
Cocrystal Pharma, Inc. 33
Codagenix, Inc. 34
FIT Biotech Oyj 35
GlaxoSmithKline plc 36
Humabs BioMed SA 37
Immunovaccine, Inc. 38
Johnson & Johnson 39
Kineta, Inc. 40
MacroGenics, Inc. 41
Medivir AB 42
Merck & Co., Inc. 43
Molplex Ltd. 44
Myelo Therapeutics GmbH 45
NanoViricides, Inc. 46
Panacea Biotec Limited 47
PaxVax 48
Prosetta Antiviral Inc. 49
RFS Pharma, LLC 50
Sanofi Pasteur SA 51
Sarepta Therapeutics, Inc. 52
SIGA Technologies, Inc. 53
SKAU Vaccines ApS 54
Takeda Pharmaceutical Company Limited 55
TechnoVax, Inc. 56
Themis Bioscience GmbH 57
United Therapeutics Corporation 58
VaxInnate Corporation 59
Visterra, Inc. 60
Dengue – Therapeutics Assessment 61
Assessment by Monotherapy Products 61
Assessment by Target 62
Assessment by Mechanism of Action 64
Assessment by Route of Administration 66
Assessment by Molecule Type 68
Drug Profiles 70
BG-323 – Drug Profile 70
celgosivir hydrochloride – Drug Profile 71
dengue (tetravalent) vaccine – Drug Profile 72
dengue (tetravalent) vaccine – Drug Profile 73
dengue (tetravalent) vaccine 4 – Drug Profile 74
dengue [DENV-2] vaccine – Drug Profile 75
dengue [rDEN1delta30, rDEN2/4delta30(ME), rDEN3delta30/31 and rDEN4delta30] (tetravalent) vaccine – Drug Profile 76
dengue [serotypes 1,2,3,4] (tetravalent) vaccine – Drug Profile 77
dengue fever vaccine – Drug Profile 80
dengue vaccine – Drug Profile 81
dengue vaccine – Drug Profile 82
dengue vaccine – Drug Profile 83
dengue vaccine – Drug Profile 85
dengue vaccine – Drug Profile 86
dengue vaccine – Drug Profile 87
dengue vaccine – Drug Profile 88
dengue vaccine – Drug Profile 89
dengue vaccine (DENV-2) – Drug Profile 90
dengue vaccine (tetravalent) – Drug Profile 91
dengue vaccine (tetravalent) – Drug Profile 93
dengue vaccine (tetravalent) – Drug Profile 94
dengue vaccine [DEN-1 and DEN-2] – Drug Profile 95
dengue vaccine [DEN-2] – Drug Profile 96
dengue vaccine 3 – Drug Profile 97
dengue vaccine 4 – Drug Profile 99
dengue vaccines – Drug Profile 100
dengue virus vaccine – Drug Profile 101
dengue virus vaccine (tetravalent) – Drug Profile 102
DengueCide – Drug Profile 103
DENV-1 PIV – Drug Profile 104
DiTU – Drug Profile 105
DV-2-DeltaGVII – Drug Profile 106
DV-2-DeltaLIG – Drug Profile 107
DV-2-G460P – Drug Profile 108
ETX-101 – Drug Profile 110
GBV-001 – Drug Profile 111
GBV-006 – Drug Profile 112
GBV-012 – Drug Profile 113
GREDEN/V1-4 – Drug Profile 114
LCTA-949 – Drug Profile 115
LVM-142 – Drug Profile 116
modipafant – Drug Profile 117
Monoclonal Antibodies for Infectious Disease – Drug Profile 118
Monoclonal Antibodies to Inhibit prM and E Proteins for Dengue – Drug Profile 119
Monoclonal Antibody for Dengue – Drug Profile 120
Monoclonal Antibody for Dengue – Drug Profile 121
Myelo-001 – Drug Profile 122
PAV-866 – Drug Profile 123
Recombinant Peptide to Inhibit Dengue Protease for Dengue – Drug Profile 124
RNAi Oligonucleotide for Dengue – Drug Profile 125
rOAS – Drug Profile 126
RS-1137 – Drug Profile 127
RS-1142 – Drug Profile 128
RS-1145 – Drug Profile 129
RS-930 – Drug Profile 130
RS-961 – Drug Profile 131
Small Molecule for Dengue – Drug Profile 132
Small Molecule for Dengue – Drug Profile 133
Small Molecule Inhibitors of NS3 Protease for Dengue and West Nile Virus Infections – Drug Profile 134
Small Molecule to Inhibit NS3 Protease for Dengue – Drug Profile 135
Small Molecules for Dengue – Drug Profile 136
Small Molecules for Dengue – Drug Profile 137
Small Molecules Inhibiting M Protein for Dengue – Drug Profile 138
Small Molecules to Activate AMPK for Dengue – Drug Profile 139
Small Molecules to Inhibit Alpha-Glucosidase I and II for Viral Infections – Drug Profile 140
Small Molecules to Inhibit Furin for Dengue – Drug Profile 142
Small Molecules to Inhibit NS3 Protease for Dengue and West Nile Virus Infections – Drug Profile 143
Small Molecules to Inhibit NS4b for Dengue – Drug Profile 144
Small Molecules to Inhibit Protease for Dengue – Drug Profile 145
Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus Infections – Drug Profile 146
Small Molecules to Inhibit Serine Protease for Viral Infections – Drug Profile 147
ST-148 – Drug Profile 148
ST-324 – Drug Profile 149
ST-610 – Drug Profile 150
Synthetic Peptides for West Nile Virus and Dengue Virus Infections – Drug Profile 151
TAK-003 – Drug Profile 152
TVX-005 – Drug Profile 154
UV-4B – Drug Profile 155
V-180 – Drug Profile 156
Viral PMO-X – Drug Profile 157
VIS-513 – Drug Profile 158
Dengue – Recent Pipeline Updates 159
Dengue – Dormant Projects 165
Dengue – Discontinued Products 167
Dengue – Product Development Milestones 168
Featured News & Press Releases 168
Appendix 180
Methodology 180
Coverage 180
Secondary Research 180
Primary Research 180
Expert Panel Validation 180
Contact Us 181
Disclaimer 181


【レポート販売概要】

■ タイトル:デング熱(Dengue)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Dengue - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6019IDB
■ 調査対象地域:グローバル
  • 溶剤型コイルコーティングの世界市場2015-2019
    About Solvent-borne Coil Coatings Coil coatings, also known as prepainted metal coatings, are used to coat metal surfaces before they are shaped into end products. They cause minimal VOC emissions, do not consume a lot of energy, and result in low wastage. They have many advantages over post-painted metal coatings, such as corrosion protection and long-term aesthetic value. Technavio's analysts fo …
  • テレハンドラーの世界市場:高さ別(50フィート未満、50フィート以上)、エンドユーザー別(建設、鉱業、農業、重工業、その他)
    The global telehandlers market was valued at $5,433.9 million in 2018, and is projected to reach $7,821.4 million by 2026, growing at a CAGR of 4.5% from 2019 to 2026. A telehandler, also known as telescopic handler or rough terrain forklift, is a lifting machine equipped with a telescopic boom to lift heavy loads and is mounted on a four-wheel drive chassis. Telehandlers are designed with varied …
  • 世界の精製産業:精製能力および投資動向
    Global Capacity and Capital Expenditure Outlook for Refineries - New-Build Refinery Pipeline Risks Over-Capacity and Puts Pressure on Refiners Summary The global refining industry, which witnessed a marginal growth rate of 6% since 2010, is expected to rebound and witness a high growth rate of 16% during 2014 to 2019. Asia will dominate the global refining industry, both in terms of capacity growt …
  • 情報セキュリティコンサルティングの世界市場予測(~2021):セキュリティ種類別(ネットワークセキュリティ、アプリケーションセキュリティ、データベースセキュリティ、エンドポイントセキュリティ)、企業規模別、産業別、地域別
    The information security consulting market size is expected to grow from USD 16.12 Billion in 2016 to USD 26.15 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period. The major growth drivers of the market include the increased network complexities due to third-party applications deployment and mergers & acquisitions across globe. Major security types in info …
  • Osteopenia:グローバル臨床試験レビューH2, 2013
    Osteopenia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H2, 2013" provides data on the Osteopenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteopenia. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
  • 世界のサンダルウッド油市場2015
    < Global Sandalwood Oil Industry Report 2015> is a professional and deep research report on Global and China Sandalwood Oil industry. For overview analysis, the report introduces Sandalwood Oil basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the re …
  • 対空・対ミサイル防衛レーダー(AMDR)の世界市場予測(~2021)
    The global air and missile defence radar (AMDR) market was valued at USD 8.79 Billion in 2016 and is projected to reach USD 12.52 Billion by 2021, at a CAGR of 7.34% from 2016 to 2021. Increased concerns towards prevention from ballistic and stealth missiles, target racking and early warning, airborne fire control, surveillance, and ground mapping, among others, are driving the demand for AMDRs ac …
  • 高性能自動車の世界市場2018-2022
    About High-performance Car A high-performance car consists of a powerful powertrain that allows the vehicle to travel at high speeds (above 150 mph). The drivetrain improves the handling and braking quality of the vehicle at high speeds. Technavio’s analysts forecast the global high-performance car market to grow at a CAGR of 6.97% during the period 2018-2022. Covered in this report The report cov …
  • 世界のタンパク質発現(Protein Expression)市場動向(~2018)
    Protein expression denotes the presence and the abundance of one or more proteins in a cell or tissue. It forms an integral part of proteomic research as many commercially important proteins are produced downstream of protein expression. The protein expression market is expected to be driven by a number of factors. In the pharmaceutical sector, decline in the productivity of R&D and the sales drop …
  • Oil India Limited:石油・ガスの開発・生産動向及びコスト分析– 2012
    Oil India Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Oil India Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
  • 計器着陸装置(ILS)及びビジュアル着艦支援(VLA)装置の世界市場
    The ILS and VLA market is estimated to be $1152.15 million in 2014 and is projected to register a CAGR of 5.54% to reach $1680.79 million by 2020. This report provides a market analysis of the ILS and VLA market over the next six years. It contains the analysis of drivers, challenges, restraints, and burning issues that impacts the aviation industry. It also discusses the industrial value-chain & …
  • 産業用バーナーの世界市場2016-2020
    About Industrial Burner In the manufacturing sector, industrial process heating operations account for a major part of the energy demand, accounting for approximately 70% of the manufacturing sector's process energy end use. Boilers are pressure vessels that are designed to either heat water or produce steam, which is then used for heat exchange operations in various end-user industries. The use o …
  • 人工心臓弁市場:企業分析
    MediPoint: Prosthetic Heart Valves - Current and Future Players Summary The global prosthetic heart valves (PHV) market is a dynamic, billion-dollar market that is saturated with numerous players developing innovative technologies. Recent advancements in the field of interventional cardiology have greatly expanded the potential of therapeutic applications. Prosthetic heart valves, including mechan …
  • 世界の溶媒蒸発市場:蒸発器種類別(ロータリー蒸発器、窒素ブローダウン蒸発器、遠心蒸発器)、エンドユーザー別(医薬&バイオ医薬品、診断研究所、研究所&学術研究所)、地域別
    “The global solvent evaporators market size is projected to grow at a CAGR of 7.3%.” The global solvent evaporators market size is expected to reach USD 694 million by 2024 from an estimated USD 487 million in 2019, at a CAGR of 7.3%. The growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large mol …
  • 世界の経肺薬物送達システム市場動向(2012-2016)
    TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. How …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。